Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ombretta Turriziani

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
International Journal of Antimicrobial Agents|June 26, 2012
Antiviral therapy: old and current issuesGuido Antonelli, Ombretta Turriziani
HIV/AIDS (Auckland, N.Z.)|February 16, 2013
Potential benefit of dolutegravir once daily: efficacy and safetyAlessandra Fantauzzi, Ombretta Turriziani, Ivano Mezzaroma
Biomedicines|January 21, 2023
The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial InterconnectionLaura Mazzuti, Ombretta Turriziani, Ivano Mezzaroma
Viruses|November 27, 2024
Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIVRoberta Campagna, Chiara Nonne, Guido Antonelli, et al.
AIDS (London, England)|July 27, 2017
Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitorsLaura Mazzuti, Ivano Mezzaroma, Francesca Falasca, et al.
World Journal of Clinical Cases|July 18, 2014
Infectious burden and atherosclerosis: A clinical issueRosa Sessa, Marisa Di Pietro, Simone Filardo, et al.
Expert Review of Anti-Infective Therapy|December 23, 2016
Consolidation of molecular testing in clinical virologyCarolina Scagnolari, Ombretta Turriziani, Katia Monteleone, et al.
Emerging Microbes & Infections|September 2, 2020
SARS-CoV-2 infection: diagnostic testing results occasionally require special attentionElisabetta Riva, Pier Paolo Sainaghi, Ombretta Turriziani, et al.
International Journal of Molecular Sciences|November 22, 2017
Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative StressMarisa Di Pietro, Simone Filardo, Francesca Falasca, et al.
Materials (Basel, Switzerland)|August 12, 2022
siRNA Transfection Mediated by Chitosan Microparticles for the Treatment of HIV-1 Infection of Human Cell LinesLaura Chronopoulou, Francesca Falasca, Federica Di Fonzo, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Antimicrobial Agents|June 26, 2012
Antiviral therapy: old and current issuesGuido Antonelli, Ombretta Turriziani
HIV/AIDS (Auckland, N.Z.)|February 16, 2013
Potential benefit of dolutegravir once daily: efficacy and safetyAlessandra Fantauzzi, Ombretta Turriziani, Ivano Mezzaroma
Biomedicines|January 21, 2023
The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial InterconnectionLaura Mazzuti, Ombretta Turriziani, Ivano Mezzaroma
Viruses|November 27, 2024
Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIVRoberta Campagna, Chiara Nonne, Guido Antonelli, et al.
AIDS (London, England)|July 27, 2017
Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitorsLaura Mazzuti, Ivano Mezzaroma, Francesca Falasca, et al.
World Journal of Clinical Cases|July 18, 2014
Infectious burden and atherosclerosis: A clinical issueRosa Sessa, Marisa Di Pietro, Simone Filardo, et al.
Expert Review of Anti-Infective Therapy|December 23, 2016
Consolidation of molecular testing in clinical virologyCarolina Scagnolari, Ombretta Turriziani, Katia Monteleone, et al.
Emerging Microbes & Infections|September 2, 2020
SARS-CoV-2 infection: diagnostic testing results occasionally require special attentionElisabetta Riva, Pier Paolo Sainaghi, Ombretta Turriziani, et al.
International Journal of Molecular Sciences|November 22, 2017
Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative StressMarisa Di Pietro, Simone Filardo, Francesca Falasca, et al.
Materials (Basel, Switzerland)|August 12, 2022
siRNA Transfection Mediated by Chitosan Microparticles for the Treatment of HIV-1 Infection of Human Cell LinesLaura Chronopoulou, Francesca Falasca, Federica Di Fonzo, et al.
Pageof 12